Novartis AG is 167.8x more valuable than Rapport Therapeutics, Inc. by market capitalization ($282.64 B vs $1.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RAPP | NVS |
|---|---|---|
| Market cap | $1.68 B | $282.64 B |
| US-listed rank | #2228 | #47 |
| Net income (latest FY) | -$111.48M | - |
| SEC filings | 197 | 947 |
Novartis AG is 167.8x more valuable than Rapport Therapeutics, Inc. by market capitalization ($282.64 B vs $1.68 B).
Full pages: Rapport Therapeutics, Inc. and Novartis AG, or browse the full rankings.